CN105707863A - 降血脂医学配方食品 - Google Patents
降血脂医学配方食品 Download PDFInfo
- Publication number
- CN105707863A CN105707863A CN201610135065.6A CN201610135065A CN105707863A CN 105707863 A CN105707863 A CN 105707863A CN 201610135065 A CN201610135065 A CN 201610135065A CN 105707863 A CN105707863 A CN 105707863A
- Authority
- CN
- China
- Prior art keywords
- radix
- polysaccharide
- fructus
- rhizoma
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 71
- 210000004369 blood Anatomy 0.000 title claims abstract description 53
- 239000008280 blood Substances 0.000 title claims abstract description 53
- 239000006041 probiotic Substances 0.000 claims abstract description 54
- 235000018291 probiotics Nutrition 0.000 claims abstract description 54
- 239000003814 drug Substances 0.000 claims abstract description 48
- 230000000694 effects Effects 0.000 claims abstract description 37
- 239000000284 extract Substances 0.000 claims abstract description 37
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 29
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 29
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 26
- 239000011707 mineral Substances 0.000 claims abstract description 26
- 150000001413 amino acids Chemical class 0.000 claims abstract description 24
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 21
- 229940088594 vitamin Drugs 0.000 claims abstract description 16
- 229930003231 vitamin Natural products 0.000 claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 claims abstract description 16
- 239000011782 vitamin Substances 0.000 claims abstract description 16
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 13
- 208000031226 Hyperlipidaemia Diseases 0.000 claims abstract description 12
- 238000000605 extraction Methods 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 6
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract 2
- 150000004676 glycans Chemical class 0.000 claims description 89
- 229920001282 polysaccharide Polymers 0.000 claims description 89
- 239000005017 polysaccharide Substances 0.000 claims description 89
- 241000894006 Bacteria Species 0.000 claims description 66
- 239000000203 mixture Substances 0.000 claims description 53
- 230000000529 probiotic effect Effects 0.000 claims description 52
- 230000000968 intestinal effect Effects 0.000 claims description 47
- 210000000582 semen Anatomy 0.000 claims description 47
- 239000003925 fat Substances 0.000 claims description 36
- 241000628997 Flos Species 0.000 claims description 34
- 235000019197 fats Nutrition 0.000 claims description 34
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 34
- 230000036541 health Effects 0.000 claims description 24
- 229940024606 amino acid Drugs 0.000 claims description 23
- 235000001014 amino acid Nutrition 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 235000018102 proteins Nutrition 0.000 claims description 22
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- 239000003921 oil Substances 0.000 claims description 20
- 235000019198 oils Nutrition 0.000 claims description 20
- 241001264174 Cordyceps militaris Species 0.000 claims description 17
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 238000005516 engineering process Methods 0.000 claims description 14
- 235000021323 fish oil Nutrition 0.000 claims description 14
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 13
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 13
- 241000233779 Cyclocarya paliurus Species 0.000 claims description 12
- 241000222336 Ganoderma Species 0.000 claims description 12
- 241000186660 Lactobacillus Species 0.000 claims description 12
- 239000002671 adjuvant Substances 0.000 claims description 12
- 235000014593 oils and fats Nutrition 0.000 claims description 12
- 241001018563 Nekemias grossedentata Species 0.000 claims description 11
- 235000008216 herbs Nutrition 0.000 claims description 11
- 230000010354 integration Effects 0.000 claims description 11
- 229940039696 lactobacillus Drugs 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 11
- 241000195620 Euglena Species 0.000 claims description 10
- 244000194101 Ginkgo biloba Species 0.000 claims description 10
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 10
- 241000229143 Hippophae Species 0.000 claims description 10
- 235000003935 Hippophae Nutrition 0.000 claims description 10
- 240000004371 Panax ginseng Species 0.000 claims description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 10
- 235000008434 ginseng Nutrition 0.000 claims description 10
- 230000003516 hyperlipidaemic effect Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 235000013557 nattō Nutrition 0.000 claims description 10
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 9
- 241000190633 Cordyceps Species 0.000 claims description 9
- 240000000599 Lentinula edodes Species 0.000 claims description 9
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 9
- 244000113306 Monascus purpureus Species 0.000 claims description 9
- 235000002322 Monascus purpureus Nutrition 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 9
- 239000004519 grease Substances 0.000 claims description 9
- 229940057059 monascus purpureus Drugs 0.000 claims description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 8
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 241001164374 Calyx Species 0.000 claims description 8
- 241001328788 Camellia nitidissima Species 0.000 claims description 8
- 241000218236 Cannabis Species 0.000 claims description 8
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 8
- 241000195493 Cryptophyta Species 0.000 claims description 8
- 235000011201 Ginkgo Nutrition 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 241000361919 Metaphire sieboldi Species 0.000 claims description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
- 241000233805 Phoenix Species 0.000 claims description 8
- 229940108924 conjugated linoleic acid Drugs 0.000 claims description 8
- 238000000855 fermentation Methods 0.000 claims description 8
- 230000004151 fermentation Effects 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 8
- 229940026510 theanine Drugs 0.000 claims description 8
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- -1 compound vitamin Chemical class 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 241001489978 Eupolyphaga Species 0.000 claims description 6
- 241000237903 Hirudo Species 0.000 claims description 6
- 241001057584 Myrrha Species 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 210000004051 gastric juice Anatomy 0.000 claims description 6
- 230000001976 improved effect Effects 0.000 claims description 6
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003094 microcapsule Substances 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 241000411851 herbal medicine Species 0.000 claims description 5
- 239000011574 phosphorus Substances 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 4
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 229920002527 Glycogen Polymers 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 4
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 4
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 4
- 244000302512 Momordica charantia Species 0.000 claims description 4
- 235000009811 Momordica charantia Nutrition 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 229960001231 choline Drugs 0.000 claims description 4
- 229910052804 chromium Inorganic materials 0.000 claims description 4
- 239000011651 chromium Substances 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- 238000005538 encapsulation Methods 0.000 claims description 4
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 229940096919 glycogen Drugs 0.000 claims description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052737 gold Inorganic materials 0.000 claims description 4
- 239000010931 gold Substances 0.000 claims description 4
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 229910052750 molybdenum Inorganic materials 0.000 claims description 4
- 239000011733 molybdenum Substances 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 239000011772 phylloquinone Substances 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- 239000011715 vitamin B12 Substances 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- 244000268590 Euryale ferox Species 0.000 claims description 3
- 235000006487 Euryale ferox Nutrition 0.000 claims description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 244000170916 Paeonia officinalis Species 0.000 claims description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 235000013325 dietary fiber Nutrition 0.000 claims description 3
- 210000003038 endothelium Anatomy 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- 230000002779 inactivation Effects 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- 239000011572 manganese Substances 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- 241000219226 Acer truncatum Species 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 241001061264 Astragalus Species 0.000 claims description 2
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 2
- 241000186012 Bifidobacterium breve Species 0.000 claims description 2
- 241001608472 Bifidobacterium longum Species 0.000 claims description 2
- 241000219357 Cactaceae Species 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 229920000742 Cotton Polymers 0.000 claims description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 2
- 240000001980 Cucurbita pepo Species 0.000 claims description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 claims description 2
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 claims description 2
- 241001523681 Dendrobium Species 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 240000001008 Dimocarpus longan Species 0.000 claims description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 2
- 235000000235 Euphoria longan Nutrition 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 240000002045 Guettarda speciosa Species 0.000 claims description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 2
- 244000010000 Hovenia dulcis Species 0.000 claims description 2
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 2
- 244000199866 Lactobacillus casei Species 0.000 claims description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 2
- 241000218492 Lactobacillus crispatus Species 0.000 claims description 2
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 2
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 2
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 2
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 2
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 2
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 2
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229920001491 Lentinan Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 244000179886 Moringa oleifera Species 0.000 claims description 2
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 2
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims description 2
- 244000183278 Nephelium litchi Species 0.000 claims description 2
- 235000019944 Olestra Nutrition 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- 241000123107 Phellinus Species 0.000 claims description 2
- 241001499733 Plantago asiatica Species 0.000 claims description 2
- 241000219238 Pleurotus abalonus Species 0.000 claims description 2
- 244000252132 Pleurotus eryngii Species 0.000 claims description 2
- 235000001681 Pleurotus eryngii Nutrition 0.000 claims description 2
- 241001300674 Plukenetia volubilis Species 0.000 claims description 2
- 241000756042 Polygonatum Species 0.000 claims description 2
- 241000186429 Propionibacterium Species 0.000 claims description 2
- 241000508269 Psidium Species 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 235000010841 Silybum marianum Nutrition 0.000 claims description 2
- 244000272459 Silybum marianum Species 0.000 claims description 2
- 229920000377 Sinistrin Polymers 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 2
- 241000586290 Suaeda salsa Species 0.000 claims description 2
- 235000006468 Thea sinensis Nutrition 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 240000004922 Vigna radiata Species 0.000 claims description 2
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 2
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 240000008866 Ziziphus nummularia Species 0.000 claims description 2
- 229940006091 aloe polysaccharide Drugs 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 2
- 229940114079 arachidonic acid Drugs 0.000 claims description 2
- 235000021342 arachidonic acid Nutrition 0.000 claims description 2
- 235000006533 astragalus Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 2
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 2
- 239000010495 camellia oil Substances 0.000 claims description 2
- 235000001122 chang geng bian tao Nutrition 0.000 claims description 2
- 229960002173 citrulline Drugs 0.000 claims description 2
- 235000013477 citrulline Nutrition 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 2
- 239000008157 edible vegetable oil Substances 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 2
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 229940106134 krill oil Drugs 0.000 claims description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 2
- 229940017800 lactobacillus casei Drugs 0.000 claims description 2
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229940115286 lentinan Drugs 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- 150000004668 long chain fatty acids Chemical class 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- 235000009973 maize Nutrition 0.000 claims description 2
- 235000020333 oolong tea Nutrition 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 2
- 238000009928 pasteurization Methods 0.000 claims description 2
- 235000002378 plant sterols Nutrition 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 235000020354 squash Nutrition 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 210000004233 talus Anatomy 0.000 claims description 2
- 229960003080 taurine Drugs 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 22
- 235000016709 nutrition Nutrition 0.000 abstract description 15
- 235000012000 cholesterol Nutrition 0.000 abstract description 10
- 230000036039 immunity Effects 0.000 abstract description 10
- 230000002708 enhancing effect Effects 0.000 abstract description 8
- 230000036772 blood pressure Effects 0.000 abstract description 6
- 235000005911 diet Nutrition 0.000 abstract description 6
- 230000035764 nutrition Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 4
- 230000037213 diet Effects 0.000 abstract description 3
- 210000002966 serum Anatomy 0.000 abstract description 3
- 201000001320 Atherosclerosis Diseases 0.000 abstract description 2
- 230000009977 dual effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 description 22
- 238000010521 absorption reaction Methods 0.000 description 15
- 230000006870 function Effects 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 13
- 238000009472 formulation Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 108090001030 Lipoproteins Proteins 0.000 description 9
- 102000004895 Lipoproteins Human genes 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 150000003722 vitamin derivatives Chemical class 0.000 description 7
- 102000053602 DNA Human genes 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108010046315 IDL Lipoproteins Proteins 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 235000015170 shellfish Nutrition 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 108010004103 Chylomicrons Proteins 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000000853 LDL receptors Human genes 0.000 description 3
- 108010001831 LDL receptors Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000221377 Auricularia Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000001741 anti-phlogistic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000000923 atherogenic effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- QYIXCDOBOSTCEI-NWKZBHTNSA-N coprostanol Chemical compound C([C@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-NWKZBHTNSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 208000020346 hyperlipoproteinemia Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 101150102415 Apob gene Proteins 0.000 description 1
- 102000006410 Apoproteins Human genes 0.000 description 1
- 108010083590 Apoproteins Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020575 Hyperammonaemia Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229930189077 Rifamycin Natural products 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241001591005 Siga Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 210000001268 chyle Anatomy 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000027700 hepatic dysfunction Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 229960003292 rifamycin Drugs 0.000 description 1
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 description 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 1
- 229960003040 rifaximin Drugs 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000002978 thoracic duct Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/179—Sakei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/41—Pediococcus
- A23V2400/413—Acidilactici
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明属于药食同源类配方与新资源食品技术领域,具体是提供了降血脂医学配方食品、特定医学配方食品或非特定医学方食品;该配方根据《特殊医学用途配方食品通则》的要求,结合高血脂患者的体质特征,根据传统中医精髓理论合理配伍多种“药食同源”之中药,采用半仿生提取法提取药食两用的中药提取物精华、多种微胶囊化的益生菌以及生物酶解提取的短肽、益生元、氨基酸、碳水化合物、有保健功能的油脂、多种维生素及矿物质一起混合等工艺加工制成,不仅可作为单一营养来源满足高血脂患者的营养需求,还起到了降低总胆固醇、降低血清甘油三酯、降低动脉粥样硬化指数、降低血压、降低血糖、降脂减肥及及增强免疫力的功效。
Description
技术领域
本发明属于药食同源类配方与新资源食品技术领域,具体是将“药食同源之中药”的传统中医精髓理论和“多重益生菌”有机结合起来,添加以短肽、益生元、氨基酸、碳水化合物、有保健功能的油脂、复合维生素、复合矿物质为辅料制成的降血脂的医学配方食品、特定医学配方食品或非特定医学配方食品。
背景技术
高血脂症是指血脂水平过高,可直接引起一些严重危害人体健康的疾病,如动脉粥样硬化、冠心病、胰腺炎等,由于脂肪代谢或运转异常使血浆一种或多种脂质高于正常称为高脂血症,脂质不溶或微溶于水必须与蛋白质结合以脂蛋白形式存在,因此,高脂血症常为高脂蛋白血症(hyperlipoproteinemia),表现为高胆固醇血症、高甘油三酯血症等,高血脂病因:(1)继发性血脂蛋白水平升高:血脂主要包括胆固醇(或称总胆固醇TC)和甘油三酯,在血循环中以非游离状态存在,和蛋白结合成脂蛋白这样的大分子运输主要的脂蛋白分类---乳糜微粒,极低密度(前-β)脂蛋白(VLDL),低密度(β-)脂蛋白(LDL),和高密度(a-)脂蛋白(HDL)---这些蛋白是紧密相联的,而分类常就物理化学特性而言(例如电泳移动率及超速离心分离后的密度),血中主要的脂蛋白转运为甘油三酯,乳糜微粒是最大的脂蛋白携带者,外源性的甘油三酯经过胸导管到静脉系统,在脂肪的毛细血管和肌肉组织中,90%的乳糜甘油三酯通过一组特定的酯酶被转运,乳糜微粒被水解成脂肪酸和甘油进入到脂肪细胞和肌肉细胞中被利用或储存,这种脂酶快速地使VLDL中的内源性甘油三酯降解,引起中密度脂蛋白(IDL)丧失甘油三酯和脱辅基蛋白,2~6小时内IDL通过分离更多的甘油三酯而进一步降解成为LDL,LDL在血浆中的半衰期为2~3天,VLDL为血浆LDL的主要来源;(2)高脂血症:由VLDL产生过多或清除障碍以及VLDL转变成LDL过多所致,肥胖,糖尿病,酒精过量,肾病综合征或基因缺陷可引起肝脏VLDL产生过多,LDL和TC增高亦常与血高甘油三酯相关联,LDL的清除障碍和apoB的结构缺陷有关,另外,清除障碍亦可能由于LDL受体数量减少或功能异常(活力降低),这可能为基因或饮食因素所致,LDL受体蛋白结构的分子缺陷是LDL受体功能异常常见的遗传学原因---基因缺陷的常见机制会在以下描述;“药食同源”是中华原创医学之中对人类最有价值的贡献之一;中医历来强调“药疗不如食疗”,食疗成为现代人追求返璞归真、健康饮食的最佳选择;让人们在享受美食的过程中祛除病痛,避免了打针、吃药,甚至手术之苦;
对于特殊营养食品,在美国、欧盟等发达国家都有相应的规定和开发应用;而我国GB29922-2013《特殊医学用途配方食品通则》食品安全国家标准中全营养食品明确规定:2.1.1全营养配方食品:可作为单一营养来源满足目标人群营养需求的特殊医学用途配方食品;2.1.2特定全营养配方食品:可作为单一营养来源满足目标人群在特定疾病或医学状况下营养需求的特殊医学用途配方食品;“劲膳美”公司参与了国家十二五科技支撑项目,项目编号:2012BAI35B00,组织单位:中国科学院,课题编号:2012BAI35B03,课题名称:针对不同疾病的临床营养治疗研究,课题牵头单位:中国医学科学院北京协和医院,中国医学科学院北京协和医院牵头北大人民医院、北京同仁医院、北京天坛医院、北京四季坛医院、北京朝阳医院负责糖尿病全营养配方食品的多中心临床评价研究;苏州大学第一附属医院牵头郑州大学第一附属医院、中大医院负责肿瘤全营养配方食品多中心的临床评价研究;重庆大学第一附属医院牵头湖南湘雅医院、四川华西医院、宁夏第一人民医院负责肝病全营养配方食品多中心的临床评价研究;
中医传统医学认为:“脾(即消化系统)为后天之本”,肠胃健康是健康之本,人体营养的99%需要靠肠道吸收,肠内疾病也是万病之源;但随着年龄越大,肠道中有益菌群(益生菌)比例逐渐减少;如双歧杆菌在婴幼儿时期占98%,到中年时降至10%,65岁以后仅占5%;人越老,益生菌越少,肠道功能也随之逐渐下降,越来越多的研究显示,正常菌群在人体消化、免疫和抗病等方面有诸多不可替代的作用;肠道菌群组成的改变与多种疾病,特别是肠道疾病的发生发展密切相关,而从已有临床研究发现:益生菌能起到调节肠道菌群,控制肠道炎症作用,是一种安全有效的干预调节方法;
高血脂与双歧杆菌的关系:血脂的主要成份是胆固醇、甘油三脂和低密度脂蛋白,而且是造成动脉硬化和高血粘的主要原因,胆固醇是胆汁的主要原料,胆汁是重要的消化液,尤其在消化脂类物质时作用非常重要,当食物进入十二指肠帮助消化,参与消化后的胆汁大部分又被小肠重复吸收,进入肝脏,增大肝脏及血液负担,同时有很大一部分则被细菌分解成粪固醇,因粪固醇不被肠所吸收,服用双歧杆菌活菌制剂,对降解代谢后产生的大量的内毒素进行了清理,及时的将肠溶物送到结肠,排出体外,故降低血液中的胆固醇含量,那么血脂就降下来了,血粘度和动脉硬化也会改善;
直接口服益生菌虽有一定效果,但是由于益生菌在肠道内无法定植,且停留、占位很少,易流失,停服后有害菌易复发,相关患者需要长期服用,治疗周期长,往往使用后复发率非常高;为缩短相关患者的治疗周期,减少停药后复发率,本团队通过近叁年来对益生菌在肠道内定植机理的关健技术研究,努力寻求改进益生菌在肠道内定植的“药食同源之中药”复方,考虑到益生菌在肠道内定植的几个关键要素:益生元的存在能起到定植作用、肠道pH环境的降低和提高益生菌细胞的肠道粘附能力等,基于上述要素,本课题组从数十种“药食同源之中药”中筛选合适的食材,首次发现了添加山药、薏仁、鸡内金、芡实和菊芋等药食同源之中药成分的提取物及水苏糖,酵母,L-谷氨酰胺等后,对外源益生菌有很强的定植作用,为肠道微生态制剂中益生菌的组方选择提供实验依据;
目前市场上有利用以食源性短肽为主要原料,添加药食两用的香菇、陈皮、枸杞、山药、茯苓、黄精等的提取物,复合维生素和矿物质组成复合配方,还有利用益生菌为主要原料的产品,但还没有发现结合降血脂的患者的体质特征,依据传统中医的精髓理论,因人而异,黄金配伍以多种药食两用的中药提取物精华、多种益生菌、短肽为主要原料,以益生元、碳水化合物、氨基酸、有保健功能的油脂、多种维生素、多种矿物质为辅料制成的医学配方食品、特定医学配方食品或类似产品。
发明目的
本发明的目的是在继承中医精髓理论治病方法上,开创性将多种改善高血脂患者的肠道微生态的益生菌与“药食同源之中药”复方的提取物有机结合起来,添加以短肽、氨基酸、碳水化合物、有保健功能的油脂、多种维生素、多种矿物质为辅料,不仅能够补充免疫力低下的高血脂患者所必需营养素,改善机体营养状况,还能并利用药食两用中草药中的功能因子调节机体功能,益生菌能起到调节肠道菌群,毒副作用小、安全有效,且人们容易接受的适合高血脂患者食用的医学配方食品、特定医学配方食品或非特定医学配方食品。
发明内容
本研发团队根据《特殊医学用途配方食品通则》的要求,结合高血脂患者的体质特征,综合当今美国哈佛大学的先进生理学、医药、营养学及临床应用等研究成果,依据“消中寓补”、“均衡调养”的传统中医的精髓理论(肝、脾、肾三脏同调为主原则),采用一种或几种药食两用的中药提取物精华及新资源食品、多种益生菌、短肽为主要原料,以益生元、碳水化合物、有保健功能的油脂、氨基酸、多种维生素及矿物质辅料,不仅可作为单一营养来源满高血脂患者的营养需求,还有抗菌抗炎、降低总胆固醇、降低血清甘油三酯、降低动脉粥样硬化指数、降低血压、降低血糖、降脂减肥及增强免疫力的功效的医学配方食品、特定医学配方食品或非特定医学配方食品(组合成的复合配方);
1、本发明配方的主要成分为:
中药提取物是根据高血脂患者的体质特征从中医理论中的肝、脾、肾三脏同调为主原则,利用药食两用中草药中的功能因子调节机体功能增强抵抗力,并选取以下几大类药物进行配伍;其中:冬虫夏草功效主要有调节免疫系统功能、抗肿瘤、抗疲劳、补肺益肾,止血化痰,秘精益气、美白祛黑等多种功效;铁皮石斛,益胃生津,滋阴清热;蛹虫草,能够调节全身功能、提高免疫能力、增强巨噬细胞的吞噬功能、促进抗体的形成,主要有保肺益肾养肝、止咳平喘祛痰、润肤防皱抗衰老、抗菌抗炎、镇静、扩张血管、降低血压、降低血糖、抗疲劳、耐缺氧等作用;红曲米,具有非常强大的降低总胆固醇、降低低密度脂蛋白胆固醇、降低血清甘油三酯、降低动脉粥样硬化指数、升高高密度脂蛋白胆固醇的显著综合疗效;纳豆,纳豆中含有的醇素,食用后可排除体内部分胆固醇、分解体内酸化型脂质;白背三七,降血糖、清热凉血,活血止痛,止血;决明子,润肠通便,降脂明目;黄精,具有补气养阴,健脾,润肺,益肾功能;荷叶,主治暑热烦渴,头痛眩晕,水肿,食少腹胀,泻痢,白带,脱肛,吐血,衄血,咯血,便血,崩漏,产后恶露不净,损伤瘀血;大麦苗,能限制部分糖和脂肪的吸收,并使体内脂肪消耗增加,有效控制肥胖,防止动脉硬化,使血压稳定,对糖尿病、心脑血管疾病有良好改善作用;莱菔子,能升能降;具有消食导滞,降气化痰的功效,主治食积气滞,脘腹胀满,嗳气,下痢后重,咳嗽痰多,喘促胸满;玉竹,养阴,润燥,除烦,止渴;麦芽,性微温,归脾、胃、肝经,能消食开胃,和中,回乳;葛根,有解肌退热,透疹,生津止渴,升阳止泻之功;玉米须,有利尿、降压、利胆和止血,显齿蛇葡萄叶,降血脂,调节血糖,保肝护肝,助消化吸收,提高免疫力,抗衰老,预防心脑血管病,排毒功效,抗菌作用,抗炎镇痛,抗肿瘤等保健作用;
本发明所述的药食两用中药提取物及新资源食品是指灵芝、金樱子、天门冬、五加皮、刺五加、刺蒺藜、柴胡、黄连、荜茇、红芪、赤芍、土鳖虫、瓜蒌、薤白、诃子、鸡血藤、木贼、山豆根、地骨皮、瓦楞子、明党参、沙苑子、红景天、何首乌、女贞子、骨碎补、丹参、蒲黄、红花、没药、姜黄、水蛭、泽泻、茵陈、大黄、桑寄生、徐长卿、罗布麻、白矾、绞股蓝、赤芍、虎杖、蜂房浆、红曲米、纳豆、白背三七、线叶金雀花、显齿蛇葡萄叶、裸藻、青钱柳叶、雨生红球藻、金花茶、圆苞车前子壳、丹凤牡丹花、广东虫草子、山楂、决明子、黄精、地龙蛋白、荷叶、大麦苗、莱菔子、玉竹、麦芽、葛根、玉米须、陈皮、桔梗、槐花、沙棘、香菇、火麻仁、白果、胡椒、人参、木瓜、凉粉草、天贝、大蒜、昆布、玫瑰茄、魔芋、茶叶茶氨酸、蛋白核小球藻、茶藨子叶状层菌发酵菌丝体、冬虫夏草、灵芝孢子粉、蛹虫草、左旋肉碱、共轭亚油酸、磷脂酰丝氨酸、盐藻提取物、鱼油提取物、啤酒酵母粉物其中的三种以上或全部的混合物;
2、多种益生菌:使益生菌能大部分通过胃的强酸环境到达肠道,以促进益生菌的增殖,调节肠内微生态平衡,促进对微量元素的吸收,增强脾胃运动功能,加速药效的吸收,改善黏膜表面的微生物群或酶的平衡,或刺激机体特异性或非特异性免疫机制,提高机体定植抗力或免疫力;Xing等用双歧杆菌和乳酸杆菌预处理肝缺血再灌注大鼠,可以明显降低肠源性内毒素血症的水平并预防肝损伤的发生;选择性肠道脱污染也是调整肠道微生态的重要措施,有研究应用肠道不吸收抗生素利福昔明(rifaximin),通过抑制肠道中产尿素酶及产氨细菌的生长,来增强抵抗力;
本发明所述的多种益生菌全部采用微胶囊化后的益生菌,其所述的益生菌为双歧杆菌、乳杆菌、嗜热链球菌、清酒乳杆菌、产丙酸丙酸杆菌、乳酸片球菌其中一种、几种或全部混合;其中双歧杆菌是指青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌、动物双歧杆菌(乳双歧杆菌)其中一种、几种或全部混合;乳杆菌是指:嗜酸乳杆菌、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌亚种、格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌、副干酪乳杆菌、卷曲乳杆菌、德氏乳杆菌保加利亚亚种、罗伊氏乳杆菌其中一种、几种或全部混合;
3、短肽:即为低聚肽,是指利用生物酶工程技术从动物或植物蛋白中分离提取的一类小分子蛋白质,其平均分子量在1000Dalton以下,易溶于水,对酸、热稳定,可以不需经过消化而直接吸收,生物利用率高,在吸收和利用上优于游离的氨基酸和完整的蛋白质,可应用于蛋白质补充食品中,尤其对于消化吸收能力低下的人群,短肽是极佳的氮源,除营养功能外,短肽还具有一系列的生理活性功能:提高小肠的消化吸收功能,增强机体免疫力,抗氧化,辅助调节血糖,辅助调节血脂,辅助降血压,抗辐射,促进矿物质吸收,增强药食两用中草药中功能因子的作用效果;
本发明所述的短肽是指玉米低聚肽、小麦低聚肽、海洋胶原肽、海洋骨原肽、大豆蛋白肽、乳清蛋白肽、卵白蛋白肽其中一种、几种或全部混合;
4、益生元:以促益生菌肠道定植、肠道收敛、降低肠道pH环境,也不被大多数的肠道腐败菌利用,但可以促进人体内有益细菌——乳杆菌、双歧杆菌的生长繁殖,从而可以抑制腐败菌生长,有助于改善和维持肠道正常功能;长期食用可以延缓衰老、通便、提高免疫力、减轻肝脏负担、提高营养素的吸收率,特别是能够改善机体对钙、铁、锌等金属离子的吸收;可选择性地促进有益菌(双歧、乳酸)的生长繁殖外,还可代谢为酸性产物如乳酸等有机酸,使结肠内pH值降低,抑制肠道有害细菌的生长;使小肠内水电解质滞留在肠腔,产生高渗效果,刺激肠蠕动引起缓泻,从而促进肠道内毒素及其他毒性物质的排出,乳果糖还可直接灭活肠道中内毒素、降低肠道pH值,已广范应用于增强降血脂的抵抗力的治疗;
本发明所述的益生元为山药、茯苓、薏仁、鸡内金、芡实、菊粉的提取物,棉子低聚糖,水苏糖,酵母,低聚异麦芽糖,低聚果糖,大豆低聚糖,低聚木糖其中的一种、几种或全部混合;
5、碳水化合物:碳水化合物是由碳、氢和氧三种元素组成,它是为人体提供热能的三种主要的营养素中最廉价的营养素,摄入充足时,在体内可迅速氧化及时提供能量,避免将宝贵的蛋白质用来提供能量,碳水化合物也是细胞膜的糖蛋白、神经组织的糖脂以及传递遗传信息的脱氧核糖核酸(DNA)的重要组成成分,而且碳水化合物中含有的糖原,当其在肝内储备充足时,肝细胞对某些有毒的化学物质和各种致病微生物产生的毒素有较强的解毒能力;
本发明所述的碳水化合物是指L-阿拉伯糖、果糖、蚌肉多糖、黄精多糖,金银花多糖、香菇多糖、白背三七多糖、茶树花多糖、枳椇子多糖、辣木叶多糖、显齿蛇葡萄叶多糖、裸藻多糖、青钱柳叶多糖、山药多糖、甘草多糖、陈皮多糖、茯苓多糖、葛根多糖、陈皮多糖、山楂多糖、灵芝多糖、车前子多糖、五味子多糖、红枣多糖、淮山活性多糖、茶藨子木层孔菌多糖、虫草多糖、石斛多糖、番石榴多糖、当归多糖、芦荟多糖、青钱柳多糖、麦冬多糖、薤白多糖、绿豆多糖、苦瓜多糖、芦笋多糖、胖大海多糖、荔枝果肉多糖、刺五加多糖、鲍鱼菇多糖、黄芪多糖、乌龙茶多糖、龙眼多糖、银杏叶多糖、人参多糖、丹参多糖、仙人掌多糖、铁筷子多糖、杏鲍菇多糖、苦瓜多糖、南瓜多糖、芦笋多糖、龙葵多糖、低聚异麦芽糖、低聚异麦芽糖醇、抗性糊精、壳寡糖、酵母β-葡聚糖、多聚果糖、海藻糖、半乳糖、乳糖、葡萄糖、麦芽糖、水溶性膳食纤维、淀粉、糖元其中的一种、几种或全部混合;
6、有保健功能的油酯是指对人身体有保健作用,并能增加终产品能量,使本发明的终产品每100g所含有的能量应不低于295kJ(70kcal);如鱼油是人体血管的清道夫,还能预防动脉硬化、中风和心脏病。鱼油是高血压、冠心病、脑中风、糖尿病、风湿性关节炎、癌症等疾病;亚麻籽油有减肥、降低胆固醇、改善肾功能等作用;牡丹籽油有降血脂和降血压,增强自身免疫,预防糖尿病,防治癌症的功效;翅果油有防止和治疗高血压,高血脂,血管硬化等病症的功效;
本发明所述的有保健功能的油脂是指亚麻籽油、α-亚麻酸、亚油酸、牡丹籽油、翅果油、水飞蓟籽油、植物甾醇酯、御米油、茶叶籽油、鱼油、鱼油提取物、花生四烯酸油脂、蔗糖聚酯、DHA藻油、磷虾油、盐地碱蓬籽油、美藤果油、盐肤木果油、中链甘油三酯、黄明胶、光皮梾木果油、长柄扁桃油、中长链脂肪酸食用油、元宝枫籽油、表没食子儿茶素没食子酸酯、甘油二酯油、叶黄素酯其中的一种、几种或全部混合;
7、氨基酸:分为必需氨基酸与非必需氨基酸,是构成蛋白质的基本单位,赋予蛋白质特定的分子结构形态,使其具有生化活性;摄取适量的蛋氨酸有助于人体内各种含硫化合物的代谢并且其所含的甲基对有毒物或药物进行甲基化而起到解毒的作用;亮氨酸能够修复肌肉,控制血糖,并给身体组织提供能量,必需氨基酸苯丙氨酸可以抑制癌瘤生长,又可以降低药物的毒副作用,赖氨酸可提高食物蛋白质的吸收和利用,达到均衡营养,促进生长发育;精氨酸有助于将血液中的氨转变为尿素而排泄出去;对于高氨血症,肝脏机能障碍等均有功效;组氨酸降低胃液酸度,缓和胃肠手术的疼痛,减轻妊娠期呕吐及胃部灼热感,抑制由植物神经紧张而引起的消化道溃烂,对过敏性疾病,如哮喘等也有功效;色氨酸可以预防糙皮病、抑郁症,改善睡眠和调节情绪;
本发明所述的氨基酸是指L-谷氨酰胺、甘氨酸、支链氨基酸、γ-氨基丁酸、珠肽粉、蛋氨酸、异亮氨酸、酪氨酸、苯丙氨酸、赖氨酸、精氨酸、组氨酸、色氨酸、瓜氨酸、鸟氨酸、牛磺酸其中的一种、几种或全部混合;
8、维生素和矿物质:维生素和矿物质是人体必需的营养素,本发明中添加的维生素为维生素和矿物质是人体必需的营养素;
本发明中添加的维生素为维生素A、维生素D、维生素E、维生素K1、维生素C、维生素B1、维生素B2、维生素B6、维生素B12、烟酸、叶酸、泛酸、胆碱、生物素其中的一种、几种或全部混合;
本发明中添加的矿物质为钙、磷、钾、钠、镁、氯、铁、锌、硒、铜、锰、碘、氟、铬、钼其中的一种、几种或全部混合,本发明所述的矿物质添加为该矿物质的有机或无机化合物;
本发明中维生素矿物质的添加量参照《特殊医学用途配方食品通则》执行,现以1000g成品为例,添加量为维生素A0.01g、维生素D0.000015g、维生素E0.12g、维生素K10.00001g、维生素C0.63g、维生素B10.016g、维生素B20.016g、维生素B60.015g、维生素B120.0023g、烟酸0.2g、叶酸0.003g、泛酸0.051g、胆碱2.5g、生物素0.000057g、钙6.2g、磷4.5g、钾10g、钠16.17g、镁1.7g、铁0.15g、锌6.2g、硒0.00012g、铜0.007g、锰0.018g、碘0.00001g、氟0.00001g、铬0.00001g、钼0.00001g;
9、本发明以微胶囊、生物酶解、半仿生提取法、喷雾干燥及冷冻干燥集成创新,构成的产业化生产的关键技术;微囊化保护技术,有效解决了口服过程中高温以及强酸胃液对益生菌的灭活;采用三层蛋白质深埋微胶囊技术,再与经生物酶解或半仿生提取法提取并微囊化处理后的中药提取物混合均匀,以解决“多重益生菌”与“药食同源之中药”组分的共存问题,具有一定的抗高温和强酸特性,有利于益生菌通过口服顺利通过胃液到达肠道内停留定植,使产品防治降血脂的功效与市场同类产品相比大幅提高;
10、采用上述集成创新工艺将各种配料混合均匀制成粉状的固体饮料、颗粒剂,并分装成10g/包,用约150ml温开水溶解后,直接饮用或经鼻饲摄入;或加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成快速、方便食品便于外出携带食用,若做成饮料则省去经喷雾干燥、少添加辅料,分装成10-65ml/瓶,每日早、中、晚饭后0.5小时各饮1瓶,所有操作均在符合《特殊医学用途配方食品良好生产规范》要求的洁净干燥环境内进行;
本特定医学配方食品的特性及其对机体的作用主要表现在以下几个方面:
1.本发明是根据《特殊医学用途配方食品通则》的要求,结合高血脂的患者的体质特征,综合当今美国哈佛大学的先进生理学、医药、营养学及临床应用等研究成果研制的,因人而异,黄金配伍;
2.本发明依据“消中寓补”、“均衡调养”的传统中医的精髓理论(肝、脾、肾三脏同调为主原则),采用多种药食两用的中药提取物精华、多种益生菌、短肽为主要原料,以益生元、碳水化合物、氨基酸、有保健功能的油脂、多种维生素及矿物质为辅料,各种配料的有机组合,将各种功能进行融合,并通过有效成分之间的协同作用,增强作用效果;
3.具有高效吸收性,利用本发明配方,各种组分采用适宜的比例搭配制备的食品,经一定量水溶解后呈等渗状态,能快速通过胃到达小肠,吸收快速、完全,可以迅速补充高血脂患者所需营养;
4.本发明配方中采用各种药食两用中草药的提取物,含有多种功能活性成分,不仅提高了功能因子的浓度,减少各种杂质的摄入,有助于减轻肝肾负担,具有增强人体抵抗力的作用,还有平肝潜阳、清热利湿、温经通阳、温肾益阳、祛痰化浊、降脂减肥及增强免疫力的功效;
5.本发明配方中所含的益生菌,多种益生菌能够维护肠道正常细菌菌群平衡,抑制病原菌的生长,防止胃肠障碍等,在肠道内合成维生素、氨基酸和提高机体对钙离子的吸收,增强人体免疫机能,预防抗生素的副作用,提高宿主对放射线的耐受性,乳杆菌显著增加肠粘膜免疫球蛋白A(SIgA)含量,对机体肠粘膜局部免疫具有调节作用,调节胃、肠微生态,能提高钙、磷、铁的利用率,促进铁和维生素D的吸收,产生维生素K及维生素B,还可以减少胆固醇的吸收;
6.本发明配方食品以多种来源的食源性生物活性短肽为氮源,因为短肽不需消化即可吸收,更有利于机体的利用,可以有效改善高血脂患者负氮平衡,而且食源性短肽能够改善肠粘膜上皮细胞的结构和功能,提高肠粘膜的吸收能力;
7.本组方采用了本团队通过近叁年来对益生菌在肠道内定植机理的关键技术研究的成果,改进益生菌在肠道内定植的“药食同源之中药”复方,结合了益生元的存在能起到定植作用、肠道pH环境的降低和提高益生菌细胞的肠道粘附能力等要素,因此该食品配方的组成大大增强了对外源益生菌的定植作用;
8.本发明配方中所含的益生元,通过促进肠内益生菌的生长繁殖,抑制腐败菌的生长,同时在肠粘膜表面形成一道保护屏障,可以抵御肠道腐败菌对肠粘膜的损伤,减少肠内有害物质的吸收,还可以促进肠道蠕动,加速肠内残留物质的排出,可以防止便秘,而且通过促进肠道益生菌的生长繁殖也可以增强机体免疫力,短肽、碳水化合物与活性多糖等生物活性物质具有协同作用;
9、本发明配方中所含的碳水化合物是为人体提供热能的三种主要的营养素,在体内可迅速氧化及时提供能量,避免将宝贵的蛋白质用来提供能量,碳水化合物也是细胞膜的糖蛋白、神经组织的糖脂以及传递遗传信息的脱氧核糖核酸(DNA)的重要组成成分,而且碳水化合物中含有的糖原,当其在肝内储备充足时,肝细胞对某些有毒的化学物质和各种致病微生物产生的毒素有较强的解毒能力;
10、本发明配方中所含的有保健功能的油脂不仅对人身体有保健作用,并为人体提供正常生活所需的能量,使本发明的终产品每100g所含有的能量应不低于295kJ(70kcal);
11、本发明配方中所含的氨基酸,是构成蛋白质的基本单位,赋予蛋白质特定的分子结构形态,使其具有生化活性,有助于人体内各种含硫化合物的代谢并且其所含的甲基对有毒物或药物进行甲基化而起到解毒的作用,能够修复肌肉,控制血糖,并给身体组织提供能量,还可提高食物蛋白质的吸收和利用,达到均衡营养,促进生长发育;
12、本发明配方食品含多种维生素和矿物质,可迅速补充高血脂的患者所需的微量营养素,短肽通过与钙、铁、锌等的螯合后,更增加了矿物质元素的吸收率;
13、本发明配方中不含脂肪和胆固醇,能够在补充蛋白质、微量营养素的同时,不会增加脂肪、胆固醇的摄入,避免了肉、蛋等髙蛋白食物的不利影响。
具体实施方式
下面通过以下实施例对本发明作进一步说明,它将有助于理解本发明;
实施案例一
实现本发明目的降血脂医学配方食品是以结合高血脂患者的体质特征,依据传统中医的精髓理论,因人而异,黄金配伍以三种以上或全部的药食两用中药提取物精华及新资源食品、益生菌、短肽为主要原料,以益生元、碳水化合物、氨基酸、有保健功能的油酯多种维生素、多种矿物质为辅料制成的医学配方食品;
其特征在于由下列原料制备而成:灵芝孢子粉8g、冬虫夏草8g、灵芝8g、金樱子7g、天门冬7g、五加皮7g、刺五加7g、刺蒺藜7g、柴胡7g、黄连6g、荜茇6g、红芪6g、赤芍6g、土鳖虫6g、瓜蒌5g、薤白5g、诃子5g、鸡血藤5g、木贼5g、山豆根5g、地骨皮5g、瓦楞子5g、明党参4g、沙苑子4g、红景天4g、何首乌4g、女贞子4g、骨碎补4g、丹参4g、蒲黄4g、红花4g、没药4g、姜黄3g、水蛭3g、泽泻3g、茵陈3g、大黄3g、桑寄生3g、徐长卿3g、罗布麻3g、白矾3g、绞股蓝3g、虎杖3g、蜂房浆3g、红曲米3g、纳豆3g、蛹虫草3g、白背三七3g、线叶金雀花3g、显齿蛇葡萄叶3g、裸藻3g、青钱柳叶3g、雨生红球藻3g、金花茶3、圆苞车前子壳3g、山楂3g、决明子3g、黄精3g、地龙蛋白3g、荷叶3g、大麦苗3g、莱菔子3g、玉竹3g、麦芽3g、葛根2g、玉米须2g、陈皮2g、桔梗2g、槐花2g、沙棘2g、香菇2g、火麻仁2g、白果2g、胡椒2g、人参2g、木瓜2g、凉粉草1g、天贝1g、大蒜1g、昆布1g、玫瑰茄1g、茶叶茶氨酸1g、丹凤牡丹花1g、广东虫草子1g、蛋白核小球藻1g、茶藨子叶状层菌发酵菌丝体1g、抗性糊精100g、啤酒酵母粉1g、左旋肉碱1g、魔芋1g、共轭亚油酸1g、磷脂酰丝氨酸1g、盐藻提取物1g、鱼油提取物1g上述三种以上或全部的混合物;再添加益生菌300g、益生元300g、短肽150g、氨基酸100g、碳水化合物100g、有保健功能的油酯100g、维生素A0.01g、维生素D0.000015g、维生素E0.12g、维生素K10.00001g、维生素C0.63g、维生素B10.016g、维生素B20.016g、维生素B60.015g、维生素B120.0023g、烟酸0.2g、叶酸0.003g、泛酸0.051g、胆碱2.5g、生物素0.000057g、钙6.2g、磷4.5g、钾10g、钠16.17g、镁1.7g、铁0.15g、锌6.2g、硒0.00012g、铜0.007g、锰0.018g、碘0.00001g、氟0.00001g、铬0.00001g、钼0.00001g;
制作时先将灵芝、金樱子、天门冬、五加皮、刺五加、刺蒺藜、柴胡、黄连、荜茇、红芪、赤芍、土鳖虫、瓜蒌、薤白、诃子、鸡血藤、木贼、山豆根、地骨皮、瓦楞子、明党参、沙苑子、红景天、何首乌、女贞子、骨碎补、丹参、蒲黄、红花、没药、姜黄、水蛭、泽泻、茵陈、大黄、桑寄生、徐长卿、罗布麻、白矾、绞股蓝、赤芍、虎杖、蜂房浆、红曲米、纳豆、白背三七、线叶金雀花、显齿蛇葡萄叶、裸藻、青钱柳叶、雨生红球藻、金花茶、圆苞车前子壳、丹凤牡丹花、广东虫草子、山楂、决明子、黄精、地龙蛋白、荷叶、大麦苗、莱菔子、玉竹、麦芽、葛根、玉米须、陈皮、桔梗、槐花、沙棘、香菇、火麻仁、白果、胡椒、人参、木瓜、凉粉草、天贝、大蒜、昆布、玫瑰茄、魔芋、茶叶茶氨酸、蛋白核小球藻、茶藨子叶状层菌发酵菌丝体上述三种以上或全部浸泡后加入β-环状糊精,用半仿生提取法提取后,经喷雾干燥而制备的粉状物质,再添加生物酶解提取的冬虫夏草、灵芝孢子粉、蛹虫草、短肽、益生元、氨基酸、左旋肉碱、共轭亚油酸、磷脂酰丝氨酸、盐藻提取物、鱼油提取物、碳水化合物、多种维生素及矿物质,并加入啤酒酵母粉、抗性糊精一起粉碎混合后进行巴氏灭菌1小时,然后添加微胶囊化后的益生菌、有保健功能的油酯并混合均匀制成粉状的固体饮料、颗粒剂,并分装成10g/包,用150mL温开水溶解后,直接饮用或经鼻饲摄入;或加入适量辅料制成胶囊、片剂或加入甜味剂和辅料制成快速、方便食品便于外出携带食用,若做成饮料则省去经喷雾干燥、少添加辅料,分装成10-65mL/瓶,每日早、中、晚饭后0.5小时各饮1瓶,所有操作均在符合《特殊医学用途配方食品良好生产规范》要求的洁净干燥环境内进行;
本发明以微胶囊、生物酶解、半仿生提取法、喷雾干燥及冷冻干燥集成创新,构成的产业化生产的关键技术;微囊化保护技术,有效解决了口服过程中高温以及强酸胃液对益生菌的灭活;采用三层蛋白质深埋微胶囊技术,再与经生物酶解或半仿生提取法提取并微囊化处理后的中药提取物混合均匀,以解决“多重益生菌”与“药食同源之中药”组分的共存问题,具有一定的抗高温和强酸特性,有利于益生菌通过口服顺利通过胃液到达肠道内停留定植,使产品防治高血脂的功效与市场同类产品相比大幅提高。
实施案例二
上述降血脂医学配方食品还包括以重量计的下列组分,药食两用的提取物及新资源食品:红曲米12g、纳豆12g、蛹虫草11g、白背三七10g、线叶金雀花10g、显齿蛇葡萄叶10g、裸藻10g、青钱柳叶10g、雨生红球藻10g、金花茶9、圆苞车前子壳9g、山楂9g、决明子9g、黄精9g、地龙蛋白8g、荷叶7g、大麦苗7g、莱菔子6g、玉竹6g、麦芽6g、葛根6g、黑木耳5g、玉米须5g、陈皮5g、桔梗5g、槐花5g、沙棘4g、香菇4g、火麻仁4g、白果4g、胡椒3g、人参3g、木瓜3g、凉粉草2g、天贝2g、大蒜3g、昆布3g、沙棘3g、玫瑰茄3g、茶叶茶氨酸1g、丹凤牡丹花1g、广东虫草子1g、蛋白核小球藻1g、茶藨子叶状层菌发酵菌丝体1g、、抗性糊精2g、啤酒酵母粉2g、左旋肉碱2g、魔芋2g、共轭亚油酸2g、磷脂酰丝氨酸1g、盐藻提取物1g、鱼油提取物1g上述三种以上或全部的混合物;再添加益生元350g、益生菌300g、短肽150g、氨基酸100g、碳水化合物100g、有保健功能的油酯100g、水溶性膳食纤维50g、维生素和矿物质25g。
实施案例三
上述降血脂医学配方食品还包括以重量计的下列组分:几种药食两用的中药提取物精华及新资源食品400g、益生元350g、短肽350g、碳水化合物300g、有保健功能的油脂300g、氨基酸100g、复合维生素和矿物质25g;每100g所含有的能量应不低于295kJ(70kcal)。
实施案例四
上述降血脂医学配方食品还包括以重量计的下列组分:短肽350g、碳水化合物300g、有保健功能的油酯300g、氨基酸100g、益生菌200g、益生元100g、复合维生素和矿物质25g;每100g所含有的能量应不低于295kJ(70kcal)。
实施案例五
上述降血脂医学配方食品还包括以重量计的下列组分:蛹虫草11g、白背三七10g、线叶金雀花10g、显齿蛇葡萄叶10g、裸藻10g、青钱柳叶10g、雨生红球藻10g、金花茶9、圆苞车前子壳9g、山楂9g、决明子9g、黄精9g、地龙蛋白8g、荷叶7g、大麦苗7g、莱菔子6g、玉竹6g、麦芽6g、葛根6g、黑木耳5g、玉米须5g、陈皮5g、桔梗5g、槐花5g、沙棘4g、香菇4g、火麻仁4g、白果4g、胡椒3g、人参3g、木瓜3g、大蒜3g、昆布3g、沙棘3g、玫瑰茄3g、茶叶茶氨酸1g、丹凤牡丹花1g、广东虫草子1g、蛋白核小球藻1g、茶藨子叶状层菌发酵菌丝体1g药食两用的提取物,啤酒酵母粉2g、纳豆12g、红曲米12g、魔芋2g、共轭亚油酸2g、磷脂酰丝氨酸1g、盐藻提取物1g、鱼油提取物1g上述三种以上或全部的混合物;再添加短肽350g、碳水化合物300g、有保健功能的油脂300g、氨基酸100g、复合维生素和矿物质25g;每100g所含有的能量应不低于295kJ(70kcal)。
实施案例六
上述降血脂医学配方食品还包括以重量计的下列组分:益生菌300g、短肽350g、碳水化合物300g、有保健功能的油酯300g、氨基酸100g、复合维生素和矿物质25g;每100g所含有的能量应不低于295kJ(70kcal)。
Claims (10)
1.降血脂医学配方食品,其特征是结合高血脂患者的体质特征,依据传统中医的精髓理论,因人而异,黄金配伍以三种以上或全部的药食两用中药提取物精华及新资源食品、益生菌、短肽为主要原料,以益生元、碳水化合物、氨基酸、有保健功能的油脂、多种维生素、多种矿物质为辅料制成的医学配方食品;
其特征在于由下列原料制备而成:灵芝孢子粉8g、冬虫夏草8g、灵芝8g、金樱子7g、天门冬7g、五加皮7g、刺五加7g、刺蒺藜7g、柴胡7g、黄连6g、荜茇6g、红芪6g、赤芍6g、土鳖虫6g、瓜蒌5g、薤白5g、诃子5g、鸡血藤5g、木贼5g、山豆根5g、地骨皮5g、瓦楞子5g、明党参4g、沙苑子4g、红景天4g、何首乌4g、女贞子4g、骨碎补4g、丹参4g、蒲黄4g、红花4g、没药4g、姜黄3g、水蛭3g、泽泻3g、茵陈3g、大黄3g、桑寄生3g、徐长卿3g、罗布麻3g、白矾3g、绞股蓝3g、虎杖3g、蜂房浆3g、红曲米3g、纳豆3g、蛹虫草3g、白背三七3g、线叶金雀花3g、显齿蛇葡萄叶3g、裸藻3g、青钱柳叶3g、雨生红球藻3g、金花茶3、圆苞车前子壳3g、山楂3g、决明子3g、黄精3g、地龙蛋白3g、荷叶3g、大麦苗3g、莱菔子3g、玉竹3g、麦芽3g、葛根2g、玉米须2g、陈皮2g、桔梗2g、槐花2g、沙棘2g、香菇2g、火麻仁2g、白果2g、胡椒2g、人参2g、木瓜2g、大蒜1g、昆布1g、玫瑰茄1g、茶叶茶氨酸1g、丹凤牡丹花1g、广东虫草子1g、蛋白核小球藻1g、茶藨子叶状层菌发酵菌丝体1g上述三种以上或全部的药食两用的提取物混合物;再添加抗性糊精100g、啤酒酵母粉1g、左旋肉碱1g、魔芋1g、共轭亚油酸1g、磷脂酰丝氨酸1g、盐藻提取物1g、鱼油提取物1g、益生菌300g、益生元300g、短肽150g、氨基酸100g、碳水化合物100g、有保健功能的油酯100g、维生素A0.01g、维生素D0.000015g、维生素E0.12g、维生素K10.00001g、维生素C0.63g、维生素B10.016g、维生素B20.016g、维生素B60.015g、维生素B120.0023g、烟酸0.2g、叶酸0.003g、泛酸0.051g、胆碱2.5g、生物素0.000057g、钙6.2g、磷4.5g、钾10g、钠16.17g、镁1.7g、铁0.15g、锌6.2g、硒0.00012g、铜0.007g、锰0.018g、碘0.00001g、氟0.00001g、铬0.00001g、钼0.00001g;
其制备方法为先将灵芝、金樱子、天门冬、五加皮、刺五加、刺蒺藜、柴胡、黄连、荜茇、红芪、赤芍、土鳖虫、瓜蒌、薤白、诃子、鸡血藤、木贼、山豆根、地骨皮、瓦楞子、明党参、沙苑子、红景天、何首乌、女贞子、骨碎补、丹参、蒲黄、红花、没药、姜黄、水蛭、泽泻、茵陈、大黄、桑寄生、徐长卿、罗布麻、白矾、绞股蓝、赤芍、虎杖、蜂房浆、红曲米、纳豆、白背三七、线叶金雀花、显齿蛇葡萄叶、裸藻、青钱柳叶、雨生红球藻、金花茶、圆苞车前子壳、丹凤牡丹花、广东虫草子、山楂、决明子、黄精、地龙蛋白、荷叶、大麦苗、莱菔子、玉竹、麦芽、葛根、玉米须、陈皮、桔梗、槐花、沙棘、香菇、火麻仁、白果、胡椒、人参、木瓜、大蒜、昆布、玫瑰茄、魔芋、茶叶茶氨酸、蛋白核小球藻、茶藨子叶状层菌发酵菌丝体上述三种以上或全部浸泡后加入β-环状糊精,用半仿生提取法提取后,经喷雾干燥而制备的粉状物质,再添加生物酶解提取的冬虫夏草、灵芝孢子粉、蛹虫草、短肽、益生元、氨基酸、左旋肉碱、共轭亚油酸、磷脂酰丝氨酸、盐藻提取物、鱼油提取物、碳水化合物、多种维生素及矿物质,并加入啤酒酵母粉、抗性糊精一起粉碎混合后进行巴氏灭菌1小时,然后添加微胶囊化后的益生菌、有保健功能的油酯并混合均匀制成粉状的固体饮料、颗粒剂,并分装成10g/包,用150mL温开水溶解后,直接饮用或经鼻饲摄入;或加入适量辅料制成胶囊、片剂或加入甜味剂和辅料制成快速、方便食品便于外出携带食用,若做成饮料则省去经喷雾干燥、少添加辅料,分装成10-65mL/瓶,每日早、中、晚饭后0.5小时各饮1瓶,所有操作均在符合《特殊医学用途配方食品良好生产规范》要求的洁净干燥环境内进行;
本发明以微胶囊、生物酶解、半仿生提取法、喷雾干燥及冷冻干燥集成创新,构成的产业化生产的关键技术;微囊化保护技术,有效解决了口服过程中高温以及强酸胃液对益生菌的灭活;采用三层蛋白质深埋微胶囊技术,再与经生物酶解或半仿生提取法提取并微囊化处理后的中药提取物混合均匀,以解决“多重益生菌”与“药食同源之中药”组分的共存问题,具有一定的抗高温和强酸特性,有利于益生菌通过口服顺利通过胃液到达肠道内停留定植,使产品防治高血脂的功效与市场同类产品相比大幅提高。
2.根据权利要求1所述的降血脂医学配方食品,其特征在于所述的药食两用中草药提取物及新资源食品部分由下列原料制备而成:灵芝、金樱子、天门冬、五加皮、刺五加、刺蒺藜、柴胡、黄连、荜茇、红芪、赤芍、土鳖虫、瓜蒌、薤白、诃子、鸡血藤、木贼、山豆根、地骨皮、瓦楞子、明党参、沙苑子、红景天、何首乌、女贞子、骨碎补、丹参、蒲黄、红花、没药、姜黄、水蛭、泽泻、茵陈、大黄、桑寄生、徐长卿、罗布麻、白矾、绞股蓝、赤芍、虎杖、蜂房浆、红曲米、纳豆、白背三七、线叶金雀花、显齿蛇葡萄叶、裸藻、青钱柳叶、雨生红球藻、金花茶、圆苞车前子壳、丹凤牡丹花、广东虫草子、山楂、决明子、黄精、地龙蛋白、荷叶、大麦苗、莱菔子、玉竹、麦芽、葛根、玉米须、陈皮、桔梗、槐花、沙棘、香菇、火麻仁、白果、胡椒、人参、木瓜、大蒜、昆布、玫瑰茄、魔芋、茶叶茶氨酸、蛋白核小球藻、茶藨子叶状层菌发酵菌丝体、冬虫夏草、灵芝孢子粉、蛹虫草、左旋肉碱、共轭亚油酸、磷脂酰丝氨酸、盐藻提取物、鱼油提取物、啤酒酵母粉其中的三种以上或全部的混合物。
3.根据权利要求1所述的降血脂医学配方食品,特征在于按照所述配方混合可制备成粉状、胶囊状、片剂状、饮料类食品。
4.根据权利要求1所述的降血脂医学配方食品,还包括以重量计的下列组分:几种药食两用的中药提取物精华及新资源食品400g、益生元350g、短肽350g、碳水化合物300g、有保健功能的油脂300g、氨基酸100g、复合维生素和矿物质25g;每100g所含有的能量应不低于295kJ(70kcal)。
5.根据权利要求1所述的降血脂医学配方食品,其特征是所述的益生菌全部采用微胶囊化后的益生菌,除嗜热链球菌、清酒乳杆菌、产丙酸丙酸杆菌、乳酸片球外,其中双歧杆菌是指青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌、动物双歧杆菌(乳双歧杆菌)其中一种、几种或全部混合;乳杆菌是指:嗜酸乳杆菌、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌亚种、格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌、副干酪乳杆菌、卷曲乳杆菌、德氏乳杆菌保加利亚亚种、罗伊氏乳杆菌其中一种、几种或全部混合。
6.根据权利要求1所述的降血脂医学配方食品,其特征是所述的益生元为山药、茯苓、薏仁、鸡内金、芡实、菊粉的提取混合物,棉子低聚糖,水苏糖,酵母,低聚异麦芽糖,低聚果糖,大豆低聚糖,低聚木糖其中的一种、几种或全部混合。
7.根据权利要求1所述的降血脂医学配方食品,其特征是所述的氨基酸为L-谷氨酰胺、γ-氨基丁酸、甘氨酸、支链氨基酸、珠肽粉、蛋氨酸、异亮氨酸、酪氨酸、苯丙氨酸、赖氨酸、精氨酸、组氨酸、色氨酸、瓜氨酸、鸟氨酸、牛磺酸其中的一种、几种或全部混合。
8.根据权利要求1所述的高血脂的医学配方食品,其特征是所述的碳水化合物为本发明所述的碳水化合物是指L-阿拉伯糖、果糖、蚌肉多糖、黄精多糖,金银花多糖、香菇多糖、白背三七多糖、茶树花多糖、枳椇子多糖、辣木叶多糖、显齿蛇葡萄叶多糖、裸藻多糖、青钱柳叶多糖、山药多糖、甘草多糖、陈皮多糖、茯苓多糖、葛根多糖、陈皮多糖、山楂多糖、灵芝多糖、车前子多糖、五味子多糖、红枣多糖、淮山活性多糖、茶藨子木层孔菌多糖、虫草多糖、石斛多糖、番石榴多糖、当归多糖、芦荟多糖、青钱柳多糖、麦冬多糖、薤白多糖、绿豆多糖、苦瓜多糖、芦笋多糖、胖大海多糖、荔枝果肉多糖、刺五加多糖、鲍鱼菇多糖、黄芪多糖、乌龙茶多糖、龙眼多糖、银杏叶多糖、人参多糖、丹参多糖、仙人掌多糖、铁筷子多糖、杏鲍菇多糖、苦瓜多糖、南瓜多糖、芦笋多糖、龙葵多糖、低聚异麦芽糖、低聚异麦芽糖醇、抗性糊精、壳寡糖、酵母β-葡聚糖、多聚果糖、海藻糖、半乳糖、乳糖、葡萄糖、麦芽糖、水溶性膳食纤维、淀粉、糖元其中的一种、几种或全部混合。
9.根据权利要求1所述的降血脂医学配方食品,其特征是所述的有保健功能的油脂为亚麻籽油、α-亚麻酸、亚油酸、牡丹籽油、翅果油、水飞蓟籽油、植物甾醇酯、御米油、茶叶籽油、鱼油、鱼油提取物、花生四烯酸油脂、蔗糖聚酯、DHA藻油、磷虾油、盐地碱蓬籽油、美藤果油、盐肤木果油、中链甘油三酯、黄明胶、光皮梾木果油、长柄扁桃油、中长链脂肪酸食用油、元宝枫籽油、表没食子儿茶素没食子酸酯、甘油二酯油、叶黄素酯其中的一种、几种或全部混合。
10.根据权利要求1所述的降血脂医学配方食品,其特征是所述的短肽为海洋胶原肽、玉米低聚肽、小麦低聚肽、海洋骨原肽、大豆蛋白肽、乳清蛋白肽、卵白蛋白肽其中一种、几种或全部混合。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610135065.6A CN105707863A (zh) | 2016-03-10 | 2016-03-10 | 降血脂医学配方食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610135065.6A CN105707863A (zh) | 2016-03-10 | 2016-03-10 | 降血脂医学配方食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105707863A true CN105707863A (zh) | 2016-06-29 |
Family
ID=56157641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610135065.6A Pending CN105707863A (zh) | 2016-03-10 | 2016-03-10 | 降血脂医学配方食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105707863A (zh) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105943801A (zh) * | 2016-06-30 | 2016-09-21 | 福建医科大学 | 一种降血压的中药组合物及其制备方法与服用方法 |
CN106492011A (zh) * | 2016-11-01 | 2017-03-15 | 陈耕 | 一种具有降血压、降血脂、降血糖功效的组合物及其制备方法和饮品 |
CN106509630A (zh) * | 2016-11-07 | 2017-03-22 | 临沂大学 | 一种适于冠心病人食用的保健面条及其制备方法 |
CN107050349A (zh) * | 2017-05-04 | 2017-08-18 | 南京苏新智慧社区服务有限公司 | 一种排毒活血的膏滋及其制备方法和应用 |
CN107319423A (zh) * | 2017-08-11 | 2017-11-07 | 烟台市华昕生物医药科技有限公司 | 一种含寡肽活性物的灵参肽组合物 |
CN107519478A (zh) * | 2017-08-29 | 2017-12-29 | 严海铭 | 净化血液和延缓衰老的药物组合物及其制备方法与应用 |
CN107752039A (zh) * | 2017-11-21 | 2018-03-06 | 常州市阿曼特化工有限公司 | 一种益生菌菌剂的制备方法 |
CN107927790A (zh) * | 2017-12-08 | 2018-04-20 | 冯纪敏 | 一种组合物及其应用 |
CN108403930A (zh) * | 2018-04-27 | 2018-08-17 | 美益添生物医药(武汉)有限公司 | 一种提高肠道中akk菌/致病菌比值的复合制剂及制备方法与应用 |
CN108478633A (zh) * | 2018-04-27 | 2018-09-04 | 美益添生物医药(武汉)有限公司 | 一种改善胰岛素抵抗的复合制剂及制备方法与应用 |
CN108567901A (zh) * | 2018-04-27 | 2018-09-25 | 美益添生物医药(武汉)有限公司 | 一种提高肠道中scfa产生菌的复合制剂及制备方法与应用 |
CN108576821A (zh) * | 2018-04-27 | 2018-09-28 | 美益添生物医药(武汉)有限公司 | 一种调控脂肪代谢基因表达的复合制剂及制备方法与应用 |
CN108813245A (zh) * | 2018-05-25 | 2018-11-16 | 山西植美馨生物科技有限公司 | 一种复合亚麻发酵口服液 |
CN109043504A (zh) * | 2018-06-27 | 2018-12-21 | 重庆璞生健康科技有限公司 | 降低高血脂、高血糖的食疗产品 |
CN109090597A (zh) * | 2018-07-09 | 2018-12-28 | 杭州纤唯康生物科技有限公司 | 一种辅助降三高组合物及其制备方法和应用 |
DE102017212564A1 (de) * | 2017-07-21 | 2019-01-24 | Martin Frettlöh | Sequentielles Co-Kultivierungsverfahren zur Herstellung eines vitamin- und proteinreichen Nahrungsmittels |
CN109259243A (zh) * | 2018-09-26 | 2019-01-25 | 广州普维君健药业有限公司 | 降三高的组合物及其制备方法和应用 |
CN109364202A (zh) * | 2018-11-19 | 2019-02-22 | 江西维莱营健高科有限公司 | 一种组合物及其制备方法和应用 |
CN109601977A (zh) * | 2018-08-07 | 2019-04-12 | 丽睿客信息科技(北京)有限公司 | 适合肝病患者食用的食品 |
IT201700115753A1 (it) * | 2017-10-13 | 2019-04-13 | Cristalfarma S R L | Integratore per attenuare i disturbi nella donna causati dall’invecchiamento |
CN110115757A (zh) * | 2019-06-18 | 2019-08-13 | 中食都庆(山东)生物技术有限公司 | 一种银杏叶提取物与豆肽复方降糖制剂及其制备方法 |
CN110331111A (zh) * | 2019-07-26 | 2019-10-15 | 浙江一鸣食品股份有限公司 | 一种辅助降血脂功能的乳酸菌组合物及其应用 |
WO2019205942A1 (zh) * | 2018-04-27 | 2019-10-31 | 美益添生物医药(武汉)有限公司 | 一种提高肠道中scfa产生菌的复合制剂及制备方法与应用 |
CN111000101A (zh) * | 2019-11-14 | 2020-04-14 | 南方医科大学 | 一种具有高效解酒护肝的组合物及包含其的饮品 |
CN113368223A (zh) * | 2020-02-25 | 2021-09-10 | 张旺凡 | 一种用于心脑血管病防治的中药复方分散片及制备方法 |
US20210393730A1 (en) * | 2020-06-17 | 2021-12-23 | Lytone Enterprise, Inc. | Herbal composition for reducing uric acid and the use in reducing uric acid, body fat, and blood glucose thereof |
CN114515009A (zh) * | 2022-03-11 | 2022-05-20 | 黑龙江乌苏里江制药有限公司 | 一种具有减肥降脂功效的组合物及其应用 |
CN115120692A (zh) * | 2022-07-09 | 2022-09-30 | 广东善百年特医食品有限公司 | 一种降低血脂的甘油二酯组合物及其制备方法 |
CN115462525A (zh) * | 2022-09-19 | 2022-12-13 | 药侠谷(北京)医药文化有限公司 | 一种血脂调节组合物及其制备方法和应用 |
CN116355816A (zh) * | 2023-05-23 | 2023-06-30 | 北京康美禾源健康科技有限公司 | 一种发酵翅果油种子的微生物及其降血脂组合物 |
CN117981875A (zh) * | 2024-04-03 | 2024-05-07 | 哈尔滨葵花药业有限公司 | 一种具有提高免疫力功能的罗伊氏粘液乳杆菌Glory LR15组合物及其制备方法 |
CN118634309A (zh) * | 2024-08-14 | 2024-09-13 | 云南中医药大学 | 一种调脾消脂组合物、其制备方法和应用 |
CN118948972A (zh) * | 2024-07-30 | 2024-11-15 | 平则匡正(广州)科技有限公司 | 一种含翅果油辅助降血脂用组合物及其制备方法 |
-
2016
- 2016-03-10 CN CN201610135065.6A patent/CN105707863A/zh active Pending
Cited By (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105943801A (zh) * | 2016-06-30 | 2016-09-21 | 福建医科大学 | 一种降血压的中药组合物及其制备方法与服用方法 |
CN106492011A (zh) * | 2016-11-01 | 2017-03-15 | 陈耕 | 一种具有降血压、降血脂、降血糖功效的组合物及其制备方法和饮品 |
CN106509630A (zh) * | 2016-11-07 | 2017-03-22 | 临沂大学 | 一种适于冠心病人食用的保健面条及其制备方法 |
CN107050349A (zh) * | 2017-05-04 | 2017-08-18 | 南京苏新智慧社区服务有限公司 | 一种排毒活血的膏滋及其制备方法和应用 |
DE102017212564A1 (de) * | 2017-07-21 | 2019-01-24 | Martin Frettlöh | Sequentielles Co-Kultivierungsverfahren zur Herstellung eines vitamin- und proteinreichen Nahrungsmittels |
US11396671B2 (en) | 2017-07-21 | 2022-07-26 | Martin Frettlöh | Sequential co-culturing method for producing a vitamin- and protein-rich food product |
CN107319423A (zh) * | 2017-08-11 | 2017-11-07 | 烟台市华昕生物医药科技有限公司 | 一种含寡肽活性物的灵参肽组合物 |
CN107519478A (zh) * | 2017-08-29 | 2017-12-29 | 严海铭 | 净化血液和延缓衰老的药物组合物及其制备方法与应用 |
US11433109B2 (en) | 2017-10-13 | 2022-09-06 | Cristalfarma S.R.L. | Supplement for mitigating woman's disorders caused by ageing |
US12005075B2 (en) | 2017-10-13 | 2024-06-11 | Cristalfarma S.R.L. | Supplement for mitigating woman's disorders caused by ageing |
CN111315238A (zh) * | 2017-10-13 | 2020-06-19 | 克里斯特法尔玛有限公司 | 用于减轻由衰老引起的女性病症的补充剂 |
WO2019073433A1 (en) * | 2017-10-13 | 2019-04-18 | Cristalfarma S.R.L. | SUPPLEMENT TO MITIGATE WOMEN'S DISORDERS CAUSED BY AGING |
IT201700115753A1 (it) * | 2017-10-13 | 2019-04-13 | Cristalfarma S R L | Integratore per attenuare i disturbi nella donna causati dall’invecchiamento |
CN107752039A (zh) * | 2017-11-21 | 2018-03-06 | 常州市阿曼特化工有限公司 | 一种益生菌菌剂的制备方法 |
CN107927790A (zh) * | 2017-12-08 | 2018-04-20 | 冯纪敏 | 一种组合物及其应用 |
CN108576821A (zh) * | 2018-04-27 | 2018-09-28 | 美益添生物医药(武汉)有限公司 | 一种调控脂肪代谢基因表达的复合制剂及制备方法与应用 |
WO2019205942A1 (zh) * | 2018-04-27 | 2019-10-31 | 美益添生物医药(武汉)有限公司 | 一种提高肠道中scfa产生菌的复合制剂及制备方法与应用 |
CN108478633A (zh) * | 2018-04-27 | 2018-09-04 | 美益添生物医药(武汉)有限公司 | 一种改善胰岛素抵抗的复合制剂及制备方法与应用 |
CN108403930A (zh) * | 2018-04-27 | 2018-08-17 | 美益添生物医药(武汉)有限公司 | 一种提高肠道中akk菌/致病菌比值的复合制剂及制备方法与应用 |
CN108478633B (zh) * | 2018-04-27 | 2021-07-27 | 美益添生物医药(武汉)有限公司 | 一种改善胰岛素抵抗的复合制剂及制备方法与应用 |
CN108567901A (zh) * | 2018-04-27 | 2018-09-25 | 美益添生物医药(武汉)有限公司 | 一种提高肠道中scfa产生菌的复合制剂及制备方法与应用 |
CN108567901B (zh) * | 2018-04-27 | 2021-07-23 | 美益添生物医药(武汉)有限公司 | 一种提高肠道中scfa产生菌的复合制剂及制备方法与应用 |
CN108813245A (zh) * | 2018-05-25 | 2018-11-16 | 山西植美馨生物科技有限公司 | 一种复合亚麻发酵口服液 |
CN109043504A (zh) * | 2018-06-27 | 2018-12-21 | 重庆璞生健康科技有限公司 | 降低高血脂、高血糖的食疗产品 |
CN109090597A (zh) * | 2018-07-09 | 2018-12-28 | 杭州纤唯康生物科技有限公司 | 一种辅助降三高组合物及其制备方法和应用 |
CN109601977A (zh) * | 2018-08-07 | 2019-04-12 | 丽睿客信息科技(北京)有限公司 | 适合肝病患者食用的食品 |
CN109259243A (zh) * | 2018-09-26 | 2019-01-25 | 广州普维君健药业有限公司 | 降三高的组合物及其制备方法和应用 |
CN109364202B (zh) * | 2018-11-19 | 2021-05-28 | 江西维莱营健高科有限公司 | 一种组合物及其制备方法和应用 |
CN109364202A (zh) * | 2018-11-19 | 2019-02-22 | 江西维莱营健高科有限公司 | 一种组合物及其制备方法和应用 |
CN110115757A (zh) * | 2019-06-18 | 2019-08-13 | 中食都庆(山东)生物技术有限公司 | 一种银杏叶提取物与豆肽复方降糖制剂及其制备方法 |
CN110331111A (zh) * | 2019-07-26 | 2019-10-15 | 浙江一鸣食品股份有限公司 | 一种辅助降血脂功能的乳酸菌组合物及其应用 |
CN111000101A (zh) * | 2019-11-14 | 2020-04-14 | 南方医科大学 | 一种具有高效解酒护肝的组合物及包含其的饮品 |
CN111000101B (zh) * | 2019-11-14 | 2021-08-13 | 南方医科大学 | 一种具有高效解酒护肝的组合物及包含其的饮品 |
CN113368223A (zh) * | 2020-02-25 | 2021-09-10 | 张旺凡 | 一种用于心脑血管病防治的中药复方分散片及制备方法 |
US20210393730A1 (en) * | 2020-06-17 | 2021-12-23 | Lytone Enterprise, Inc. | Herbal composition for reducing uric acid and the use in reducing uric acid, body fat, and blood glucose thereof |
US12290548B2 (en) * | 2020-06-17 | 2025-05-06 | Lytone Enterprise, Inc. | Herbal composition for reducing uric acid and the use in reducing uric acid, body fat, and blood glucose thereof |
CN114515009A (zh) * | 2022-03-11 | 2022-05-20 | 黑龙江乌苏里江制药有限公司 | 一种具有减肥降脂功效的组合物及其应用 |
CN114515009B (zh) * | 2022-03-11 | 2023-11-24 | 黑龙江乌苏里江制药有限公司 | 一种具有减肥降脂功效的组合物及其应用 |
CN115120692A (zh) * | 2022-07-09 | 2022-09-30 | 广东善百年特医食品有限公司 | 一种降低血脂的甘油二酯组合物及其制备方法 |
CN115462525A (zh) * | 2022-09-19 | 2022-12-13 | 药侠谷(北京)医药文化有限公司 | 一种血脂调节组合物及其制备方法和应用 |
CN116355816A (zh) * | 2023-05-23 | 2023-06-30 | 北京康美禾源健康科技有限公司 | 一种发酵翅果油种子的微生物及其降血脂组合物 |
CN117981875A (zh) * | 2024-04-03 | 2024-05-07 | 哈尔滨葵花药业有限公司 | 一种具有提高免疫力功能的罗伊氏粘液乳杆菌Glory LR15组合物及其制备方法 |
CN118948972A (zh) * | 2024-07-30 | 2024-11-15 | 平则匡正(广州)科技有限公司 | 一种含翅果油辅助降血脂用组合物及其制备方法 |
CN118948972B (zh) * | 2024-07-30 | 2025-05-13 | 平则匡正(广州)科技有限公司 | 一种含翅果油辅助降血脂用组合物及其制备方法 |
CN118634309A (zh) * | 2024-08-14 | 2024-09-13 | 云南中医药大学 | 一种调脾消脂组合物、其制备方法和应用 |
CN118634309B (zh) * | 2024-08-14 | 2024-10-11 | 云南中医药大学 | 一种调脾消脂组合物、其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105707863A (zh) | 降血脂医学配方食品 | |
CN105852101A (zh) | 冠心病的医学配方食品 | |
CN105341906A (zh) | 糖尿病医学配方食品 | |
CN105614851A (zh) | 肝性脑病医学配方食品 | |
CN105852100A (zh) | 动脉粥样硬化医学配方食品 | |
CN104839664A (zh) | 骨质疏松医学配方食品 | |
CN105029405A (zh) | 慢性胃炎医学配方食品 | |
CN105394763A (zh) | 孕妇糖尿病全营养配方食品 | |
CN105410896A (zh) | 肝源性糖尿病全营养配方食品 | |
CN105831749A (zh) | 高血压医学配方食品 | |
CN104223057A (zh) | 肝病全营养配方食品 | |
CN105380265A (zh) | 肝癌医学配方食品 | |
CN105380263A (zh) | 孕妇便秘全营养配方食品 | |
CN105361146A (zh) | 一种肝病患者食用的全营养特殊配方食品 | |
CN105029400A (zh) | 类风湿关节炎医学配方食品 | |
CN104187651A (zh) | 尿酸高全营养配方食品 | |
CN104146254B (zh) | 高血压全营养配方食品 | |
CN105326038A (zh) | 孕妇孕吐全营养配方食品 | |
CN104323240A (zh) | 大肠癌全营养配方食品 | |
CN104839642A (zh) | 卵巢癌医学配方食品 | |
CN104381786A (zh) | 根除幽门螺杆菌的全营养配方食品 | |
CN104146267B (zh) | 红斑狼疮全营养配方食品 | |
CN104839645A (zh) | 肾癌医学配方食品 | |
CN104225581A (zh) | 肺结核全营养配方食品 | |
CN104323278A (zh) | 肝癌全营养配方食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160629 |